NasdaqGM - Nasdaq Real Time Price USD

KalVista Pharmaceuticals, Inc. (KALV)

10.72 +0.23 (+2.19%)
As of 12:15 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
4/30/2023
4/30/2022
4/30/2021
4/30/2020
Total Revenue
--
--
--
--
12,690.00
Operating Expense
123,718.00
110,871.00
96,613.00
57,923.00
53,223.00
Operating Income
-123,718.00
-110,871.00
-96,613.00
-57,923.00
-40,533.00
Net Non Operating Interest Income Expense
3,191.00
2,232.00
1,090.00
903.00
1,830.00
Other Income Expense
12,227.00
15,732.00
13,184.00
10,776.00
9,463.00
Pretax Income
-108,300.00
-92,907.00
-82,339.00
-46,244.00
-29,240.00
Tax Provision
--
--
--
--
-124.00
Net Income Common Stockholders
-108,300.00
-92,907.00
-82,339.00
-46,244.00
-29,116.00
Diluted NI Available to Com Stockholders
-108,300.00
-92,907.00
-82,339.00
-46,244.00
-29,116.00
Basic EPS
-3.12
-3.33
-3.36
-2.42
-1.64
Diluted EPS
-3.12
-3.33
-3.36
-2.42
-1.64
Basic Average Shares
34,458.96
27,890.85
24,473.09
19,094.44
17,748.67
Diluted Average Shares
34,458.96
27,890.85
24,473.09
19,094.44
17,748.67
Total Operating Income as Reported
-123,718.00
-110,871.00
-96,613.00
-57,923.00
-40,533.00
Total Expenses
123,718.00
110,871.00
96,613.00
57,923.00
53,223.00
Net Income from Continuing & Discontinued Operation
-108,300.00
-92,907.00
-82,339.00
-46,244.00
-29,116.00
Normalized Income
-108,904.00
-92,997.00
-80,802.00
-47,091.00
-28,749.73
Interest Income
3,191.00
2,232.00
1,090.00
903.00
1,830.00
Net Interest Income
3,191.00
2,232.00
1,090.00
903.00
1,830.00
EBIT
-123,718.00
-110,871.00
-96,613.00
-57,923.00
-40,533.00
EBITDA
-122,933.00
-110,153.00
-96,049.00
-57,386.00
-40,021.00
Reconciled Depreciation
785.00
718.00
564.00
537.00
512.00
Net Income from Continuing Operation Net Minority Interest
-108,300.00
-92,907.00
-82,339.00
-46,244.00
-29,116.00
Total Unusual Items Excluding Goodwill
604.00
90.00
-1,537.00
847.00
-367.00
Total Unusual Items
604.00
90.00
-1,537.00
847.00
-367.00
Normalized EBITDA
-123,537.00
-110,243.00
-94,512.00
-58,233.00
-39,654.00
Tax Rate for Calcs
--
--
--
--
0.00
Tax Effect of Unusual Items
--
--
--
--
-0.73
4/30/2020 - 4/9/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PHVS Pharvaris N.V.
24.35
+6.95%
 
ENTA Enanta Pharmaceuticals, Inc.
12.50
+0.16%
 
PCVX Vaxcyte, Inc.
60.03
-0.05%
 
PRAX Praxis Precision Medicines, Inc.
56.23
+6.34%
 
KURA Kura Oncology, Inc.
19.46
+2.42%
 
REPL Replimune Group, Inc.
6.44
+4.64%
 
IMVT Immunovant, Inc.
27.56
-0.68%
 
MGTX MeiraGTx Holdings plc
4.7850
+1.59%
 
IGMS IGM Biosciences, Inc.
8.27
+8.10%
 
PHAT Phathom Pharmaceuticals, Inc.
9.28
+1.97%